Murphy S, Roberts R: “Black box” 101: how the Food and Drug Administration evaluates, communicates, and manages drug benefit/risk. J Allergy Clin Immunol117: 34, 2006.1638758110.1016/j.jaci.2005.10.031)| false
US Food and Drug Administration. Guidance. Drug safety information—FDA's communication to the public. Available at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/drug-safety-information-fdas-communication-public-0. Accessed December 3, 2019.)| false
US Food and Drug Administration. FDA Adverse Event Reporting System (FAERS) public dashboard. Available at: http://www.fda.gov/drugs/guidancecomplianceregulatoryinformation/surveillance/adversedrugeffects/ucm070093.htm. Accessed March 19, 2018.)| false
US Food and Drug Administration. Index to drug-specific information. Available at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/drug-safety-information-fdas-communication-public-0. Accessed December 3, 2019.)| false
Panagiotou OA, Contopoulos-loannidis DG, Papanikolaou PN, et al: Different black box warning labeling for same-class drugs. J Gen Intern Med26: 603, 2011.21286838http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000290576600010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.1007/s11606-011-1633-9)| true
Podiatric Physicians have an ethical obligation to prescribe responsibly and cautiously to diminish and minimize the growth of drug adverse effects. Clinicians who prescribe, dispense, and administer medications must be vigilant in continually reviewing new Black Box Warnings for medications they use for their patients. The safe and appropriate selection of medications and prescribing strategies are presented. First, the concept and process for these FDA black box warnings are introduced. Then, to enrich the podiatric physician's body of knowledge, several FDA boxed warnings from 27 selected drug products that may be prescribed by podiatric physicians are presented graphically as a table. Finally, strategies for safe prescribing of these drugs with boxed warnings are presented.
Corresponding author: Robert G. Smith, DPM, MSc, RPh, CPed, Shoe String Podiatry, 723 Lucerne Cir, Ormond Beach, FL 32174. (E-mail: email@example.com)